Analysts await InvenSense, Inc. (NASDAQ:INVN) to report earnings on May, 09 for the fiscal quarter ending Mar 2016.

They expect $-0.06 EPS, down 166.67% or $0.1 from last year’s $0.04 per share.

At the moment 12 analysts are watching InvenSense, Inc. (NASDAQ:INVN), 1 rate it “Buy”, 2 “Outperform”, 9 “Underperform”, 0 “Sell”, while 0 “Hold”.

Looking forward, for the quarter ending Sep-16, 9 analysts have a mean sales target of 99.07 million. For the quarter ending Dec-16, 9 analysts have a mean sales target of 118.61 million whilst for the year ending Mar-16, 12 analysts have a mean target of 421.35 million.

In terms of earnings per share, 10 analysts have a 0.10 EPS mean target for the quarter ending Sep-16, for the quarter ending Dec-16, 10 analysts have a 0.18 EPS mean target and for the quarter ending Dec-16 there are 12 estimates of 0.47 EPS.

The biggest institutional shareholders in InvenSense, Inc. include Artiman, LLC which owns 7 million shares in the company valued at $73.30 million. Vanguard Group Inc is the second biggest holder with 5 million shares currently valued at 55.32 million whilst T. Rowe Price Associates, Inc. has 3 million shares valued at 29.63 million.

Total shares held by institutions as of the most recent company filings are 44,418,734 with a reported 3,833,151 bought and 3,164,855 sold. These holdings make up 48.08% of the company’s outstanding shares.

Currently insiders hold 592,241 shares in the business which makes up 0.64% of shares. The biggest holder currently is Mr. Behrooz L. Abdi who owns 279,897 shares (0.30% of those outstanding), whilst Dr. Ram Krishnan, Ph.D. holds 100,000 (0.11% of shares outstanding) and Adam H. Tachner holds 70,892 (0.08% of shares outstanding).

The stock increased 2.63% or $0.19 during the last trading session, hitting $7.99. InvenSense, Inc. (NASDAQ:INVN) has fallen 57.7% over the past 6 months and is downtrending.